- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: insulin degludec/insulin aspart 45
Total 2793 results
-
Novo Nordisk A/SCompletedHealthy | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1India
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Halozyme TherapeuticsCompleted
-
Biocon LimitedCompletedType2 Diabetes MellitusIndia
-
Jeff Burns, MDCompleted
-
Weill Cornell Medical College in QatarNovo Nordisk A/STerminated
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1Austria
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1 DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Germany
-
University of WashingtonCompletedType 1 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
Mannkind CorporationTerminated
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Spain, Germany, Puerto Rico, Austria
-
LMC Diabetes & Endocrinology Ltd.Unknown
-
Gan and Lee Pharmaceuticals, USARecruitingDiabetes Mellitus, Type 2China
-
Jiangsu HengRui Medicine Co., Ltd.CompletedType 2 DiabetesAustralia, China, United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Saudi Arabia
-
Medical University of WarsawCompletedDiabetes Mellitus, Type 1Poland
-
Rijnstate HospitalCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Germany, Poland, Argentina, Puerto Rico
-
Eli Lilly and CompanyCompletedType 1 DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Assaf-Harofeh Medical CenterTerminated
-
Julphar Gulf Pharmaceutical IndustriesProfil Institut für Stoffwechselforschung GmbHCompleted
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
M.D. Anderson Cancer CenterNovo Nordisk A/STerminatedLymphoma | LeukemiaUnited States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusChina, Argentina, Mexico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Argentina
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
Odense University HospitalCompletedType 2 Diabetes MellitusDenmark
-
Aristotle University Of ThessalonikiCompleted
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 1United States
-
Emory UniversityCompleted
-
Medical University of WarsawNot yet recruitingDiabetes Mellitus, Type 1
-
Novo Nordisk A/SCompleted
-
Manchester University NHS Foundation TrustNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom
-
Hadassah Medical OrganizationUnknownCystic Fibrosis | Impaired Glucose Tolerance | Pulmonary ExacerbationIsrael
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States
-
University Hospital, Basel, SwitzerlandCompletedHyperglycemiasSwitzerland
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
Centre Europeen d'Etude du DiabeteNovo Nordisk A/S; AbbottCompletedDiabetes MellitusFrance
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Croatia, Poland, Romania, South Africa, Turkey
-
Novo Nordisk A/SEnrolling by invitation
-
Halozyme TherapeuticsCompleted